🇺🇸 FDA
Patent

US 7026461

Engineered protein kinases which can utilize nucleotide triphosphate substrates

expired A61KA61K38/00A61P

Quick answer

US patent 7026461 (Engineered protein kinases which can utilize nucleotide triphosphate substrates) held by THE TRUSTEES OF PRINCETON UNIVERSITY expires Mon Apr 06 2026 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
THE TRUSTEES OF PRINCETON UNIVERSITY
Grant date
Tue Apr 11 2006 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 06 2026 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61K, A61K38/00, A61P, A61P25/28, A61P31/18